Getting to the guts of the matter for autism is exactly what a group of investigators, led by scientists at Arizona State University (ASU), hopes to accomplish with its novel approach to effective autism treatments by focusing on improving the gut microbiome through fecal microbial transplants. While initial results from a small human study are promising, additional testing will be necessary before an FDA-approved therapy would be available or recommended to the public. The research team was led by ASU’s James Adams, a professor of materials science and engineering. The study results were published in the journal Microbiome.

Also see:  

• Researchers Are Studying Fecal Transplant as a Potential Treatment for Autism, Huffington Post, Jan. 31
• Fecal transplant shows early promise against autism, Chicago Tribune, Jan. 30
• Fecal Microbial Transplant Shows Potential for Treating Autism Symptoms
• Autism symptoms improve after fecal transplant, small study finds
• Fecal transplant reduces autism symptoms in children in small study